BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

765 related articles for article (PubMed ID: 22546197)

  • 1. Mesenchymal stem cells augment neurogenesis in the subventricular zone and enhance differentiation of neural precursor cells into dopaminergic neurons in the substantia nigra of a parkinsonian model.
    Park HJ; Shin JY; Lee BR; Kim HO; Lee PH
    Cell Transplant; 2012; 21(8):1629-40. PubMed ID: 22546197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transiently impaired neurogenesis in MPTP mouse model of Parkinson's disease.
    He XJ; Nakayama H
    Neurotoxicology; 2015 Sep; 50():46-55. PubMed ID: 26215120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple neurogenic and neurorescue effects of human mesenchymal stem cell after transplantation in an experimental model of Parkinson's disease.
    Cova L; Armentero MT; Zennaro E; Calzarossa C; Bossolasco P; Busca G; Lambertenghi Deliliers G; Polli E; Nappi G; Silani V; Blandini F
    Brain Res; 2010 Jan; 1311():12-27. PubMed ID: 19945443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced de novo neurogenesis and dopaminergic neurogenesis in the substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease-like mice.
    Shan X; Chi L; Bishop M; Luo C; Lien L; Zhang Z; Liu R
    Stem Cells; 2006 May; 24(5):1280-7. PubMed ID: 16424396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Docosahexaenoic acid promotes dopaminergic differentiation in induced pluripotent stem cells and inhibits teratoma formation in rats with Parkinson-like pathology.
    Chang YL; Chen SJ; Kao CL; Hung SC; Ding DC; Yu CC; Chen YJ; Ku HH; Lin CP; Lee KH; Chen YC; Wang JJ; Hsu CC; Chen LK; Li HY; Chiou SH
    Cell Transplant; 2012; 21(1):313-32. PubMed ID: 21669041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The proliferative capacity of the subventricular zone is maintained in the parkinsonian brain.
    van den Berge SA; van Strien ME; Korecka JA; Dijkstra AA; Sluijs JA; Kooijman L; Eggers R; De Filippis L; Vescovi AL; Verhaagen J; van de Berg WD; Hol EM
    Brain; 2011 Nov; 134(Pt 11):3249-63. PubMed ID: 22075520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective effect of human mesenchymal stem cells in an animal model of double toxin-induced multiple system atrophy parkinsonism.
    Park HJ; Bang G; Lee BR; Kim HO; Lee PH
    Cell Transplant; 2011; 20(6):827-35. PubMed ID: 21054946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration in the differentiation-related molecular expression in the subventricular zone in a mouse model of Parkinson's disease.
    Oizumi H; Hayashita-Kinoh H; Hayakawa H; Arai H; Furuya T; Ren YR; Yasuda T; Seki T; Mizuno Y; Mochizuki H
    Neurosci Res; 2008 Jan; 60(1):15-21. PubMed ID: 17963913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased progenitor cell proliferation and astrogenesis in the partial progressive 6-hydroxydopamine model of Parkinson's disease.
    Aponso PM; Faull RL; Connor B
    Neuroscience; 2008 Feb; 151(4):1142-53. PubMed ID: 18201835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
    Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
    J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranigral transplantation of epigenetically induced BDNF-secreting human mesenchymal stem cells: implications for cell-based therapies in Parkinson's disease.
    Somoza R; Juri C; Baes M; Wyneken U; Rubio FJ
    Biol Blood Marrow Transplant; 2010 Nov; 16(11):1530-40. PubMed ID: 20542127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recovery of behavioral symptoms in hemi-parkinsonian rhesus monkeys through combined gene and stem cell therapy.
    Zhou Y; Sun M; Li H; Yan M; He Z; Wang W; Wang W; Lu S
    Cytotherapy; 2013 Apr; 15(4):467-80. PubMed ID: 23403361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of Parkinson's disease.
    Bertilsson G; Patrone C; Zachrisson O; Andersson A; Dannaeus K; Heidrich J; Kortesmaa J; Mercer A; Nielsen E; Rönnholm H; Wikström L
    J Neurosci Res; 2008 Feb; 86(2):326-38. PubMed ID: 17803225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
    Kanagaraj N; Beiping H; Dheen ST; Tay SS
    Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human adipose-derived mesenchymal stromal cells increase endogenous neurogenesis in the rat subventricular zone acutely after 6-hydroxydopamine lesioning.
    Schwerk A; Altschüler J; Roch M; Gossen M; Winter C; Berg J; Kurtz A; Steiner B
    Cytotherapy; 2015 Feb; 17(2):199-214. PubMed ID: 25457280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newborn dopaminergic neurons are associated with the migration and differentiation of SVZ-derived neural progenitors in a 6-hydroxydopamin-injected mouse model.
    Xie MQ; Chen ZC; Zhang P; Huang HJ; Wang TT; Ding YQ; Qi SS; Zhang C; Chen SX; Zhou P; Shao CC; Liao M; Sun CY
    Neuroscience; 2017 Jun; 352():64-78. PubMed ID: 28385636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson's disease model.
    Kim NK; Choi BH; Huang X; Snyder BJ; Bukhari S; Kong TH; Park H; Park HC; Park SR; Ha Y
    Eur J Neurosci; 2009 Mar; 29(5):891-900. PubMed ID: 19245369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action.
    Kim YJ; Park HJ; Lee G; Bang OY; Ahn YH; Joe E; Kim HO; Lee PH
    Glia; 2009 Jan; 57(1):13-23. PubMed ID: 18661552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine receptor D3 expressed on CD4+ T cells favors neurodegeneration of dopaminergic neurons during Parkinson's disease.
    González H; Contreras F; Prado C; Elgueta D; Franz D; Bernales S; Pacheco R
    J Immunol; 2013 May; 190(10):5048-56. PubMed ID: 23589621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal Stem Cells Increase Hippocampal Neurogenesis and Neuronal Differentiation by Enhancing the Wnt Signaling Pathway in an Alzheimer's Disease Model.
    Oh SH; Kim HN; Park HJ; Shin JY; Lee PH
    Cell Transplant; 2015; 24(6):1097-109. PubMed ID: 24612635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.